期刊文献+
共找到15篇文章
< 1 >
每页显示 20 50 100
Sepsis caused by endoscopic clipping for colonic diverticular bleeding: A rare complication 被引量:3
1
作者 Keiichiro Kume Masahiro Yamasaki Ichiro Yoshikawa 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第30期3817-3818,共2页
We herein report the rare complication of sepsis caused by endoscopic clipping for colonic diverticular bleeding. A 78-year-old man with a 12-h history of near syncope and painless hematochezia was admitted to our hos... We herein report the rare complication of sepsis caused by endoscopic clipping for colonic diverticular bleeding. A 78-year-old man with a 12-h history of near syncope and painless hematochezia was admitted to our hospital. Following the transfusion of 4 U of blood and continued hematochezia, a colonoscopy was performed. Active bleeding was seen as continuous arterial spurting from a single diverticulum located in the middle ascending colon. This diverticulum was seamed by four endoclips. The next day, the patient became febrile with a temperature of 39.2℃. Laboratory data included a white blood cell count of 18 100/mm3 and a C-reactive protein level of 3.4 mg/dL. He was diagnosed with sepsis since Escherichia coli was detected in the blood culture. Antibiotics were started. Four days later his fever had improved and laboratory data improved 9 d later. 展开更多
关键词 Colonic diverticular bleeding Endoscopicclipping Rare complication Endoscopic hemostasis sepsis
下载PDF
Postpolypectomy syndrome without abdominal pain led to sepsis/septic shock and gastrointestinal bleeding:A case report
2
作者 Fang-Zhi Chen Lin Ouyang +2 位作者 Xiao-Li Zhong Jin-Xiu Li Yan-Yan Zhou 《World Journal of Gastrointestinal Surgery》 SCIE 2023年第10期2343-2350,共8页
BACKGROUND Postpolypectomy syndrome(PPS)is a rare postoperative complication of colonic polypectomy.It presents with abdominal pain and fever accompanied by coagulopathy and elevated inflammatory markers.Its prognosis... BACKGROUND Postpolypectomy syndrome(PPS)is a rare postoperative complication of colonic polypectomy.It presents with abdominal pain and fever accompanied by coagulopathy and elevated inflammatory markers.Its prognosis is usually good,and it only requires outpatient treatment or observation in a general ward.How-ever,it can be life-threatening.CASE SUMMARY The patient was a 58-year-old man who underwent two colonic polypectomies,each resulting in life-threatening sepsis,septic shock,and coagulopathy.Each of the notable manifestations was a rapid drop in blood pressure,an increase in heart rate,loss of consciousness,and heavy sweating,accompanied by shortness of breath and decreased oxygen in the finger pulse.Based on the criteria of organ dysfunction due to infection,we diagnosed him with sepsis.The patient also experienced severe gastrointestinal bleeding after the second operation.Curiously,he did not complain of any abdominal pain throughout the course of the illness.He had significantly elevated concentrations of inflammatory markers and coagulopathy.Except for the absence of abdominal pain,his fever,significant coagulopathy,and elevated inflammatory marker concentrations were all consistent with PPS.Abdominal computed tomography and superior mesenteric artery computed tomography angiography showed no free air or vascular damage.Thus,the diagnosis of colon perforation was not considered.The final blood culture results indicated Moraxella osloensis.The patient was transferred to the intensive care unit and quickly improved after fluid resuscitation,antibiotic treatment,oxygen therapy,and blood transfusion.CONCLUSION PPS may induce dysregulation of the systemic inflammatory response,which can lead to sepsis or septic shock,even in the absence of abdominal pain. 展开更多
关键词 Postpolypectomy syndrome Abdominal pain sepsis Gastrointestinal bleeding Case report
下载PDF
Post-polypectomy bleeding and thromboembolism risks associated with warfarin vs direct oral anticoagulants 被引量:6
3
作者 Naohiro Yanagisawa Naoyoshi Nagata +6 位作者 Kazuhiro Watanabe Tatsuhiro Iida Mariko Hamada Sakurako Kobayashi Takuro Shimbo Junichi Akiyama Naomi Uemura 《World Journal of Gastroenterology》 SCIE CAS 2018年第14期1540-1549,共10页
AIM To verify the validity of the endoscopy guidelines for patients taking warfarin or direct oral anticoagulants(DOAC).METHODS We collected data from 218 patients receiving oral anticoagulants(73 DOAC users, 145 warf... AIM To verify the validity of the endoscopy guidelines for patients taking warfarin or direct oral anticoagulants(DOAC).METHODS We collected data from 218 patients receiving oral anticoagulants(73 DOAC users, 145 warfarin users) and 218 patients not receiving any antithrombotics(age-and sexmatched controls) who underwent polypectomy.(1) We evaluated post-polypectomy bleeding(PPB) risk in patients receiving warfarin or DOAC compared with controls;(2) we assessed the risks of PPB and thromboembolism between three AC management methods: Discontinuing AC with heparin bridge(HPB)(endoscopy guideline recommendation), continuing AC, and discontinuing AC without HPB.RESULTS PPB rate was significantly higher in warfarin users and DOAC users compared with controls(13.7% and 13.7% vs 0.9%, P < 0.001), but was not significantly different between rivaroxaban(13.2%), dabigatran(11.1%), and apixaban(13.3%) users. Two thromboembolic events occurred in warfarin users, but none in DOAC users. Compared with the continuing anticoagulant group, the discontinuing anticoagulant with HPB group(guideline recommendation) had a higher PPB rate(10.8% vs 19.6%, P = 0.087). These findings were significantly evident in warfarin but not DOAC users. One thrombotic event occurred in the discontinuing anticoagulant with HPB group and the discontinuing anticoagulant without HPB group; none occurred in the continuing anticoagulant group.CONCLUSION PPB risk was similar between patients taking warfarin and DOAC. Thromboembolism was observed in warfarin users only. The guideline recommendations for HPB should be re-considered. 展开更多
关键词 high-risk ENDOSCOPIC procedures Novel oral ANTICOAGULANTS ENDOSCOPIC guideline validation Postprocedure gastrointestinal bleeding
下载PDF
Platelet indices in neonatal sepsis: A review
4
作者 Ramesh Bhat Y 《World Journal of Clinical Infectious Diseases》 2017年第1期6-10,共5页
Thrombocytopenia is a common hematological abnormality in neonates with sepsis. The autoanalyzers now-a-days readily provide platelet indices along with platelet counts without any additional cost. However these indic... Thrombocytopenia is a common hematological abnormality in neonates with sepsis. The autoanalyzers now-a-days readily provide platelet indices along with platelet counts without any additional cost. However these indices are not given proper weightage often.The important platelet indices available for clinical utility include mean platelet volume(MPV), platelet distribution width and plateletcrit that are related to morphology and proliferation kinetics of platelets. Studies in adult patients reported their role in the diagnosis of severe sepsis and prognosis of adverse clinical outcomes including mortality. Abnormal MPV can aid diagnosing the cause of thrombocytopenia. Low MPV associated with thrombocytopenia has been found to result in clinical bleeding.Other indices, however, are less studied. The studies addressing the importance of these platelet indices in neonatal sepsis are limited. The current review gives an overview of potential utility of important platelet indices in neonatal sepsis. 展开更多
关键词 sepsis PLATELET indices THROMBOCYTOPENIA bleeding NEONATE
下载PDF
Experimental models of high-risk bowel anastomosis in rats:A systematic review
5
作者 Georgios Ntampakis Manousos-Georgios Pramateftakis +8 位作者 Elissavet Anestiadou Stefanos Bitsianis Orestis Ioannidis Chryssa Bekiari George Koliakos Maria Karakota Anastasia Tsakona Angeliki Cheva Stamatios Angelopoulos Fourth 《World Journal of Experimental Medicine》 2024年第2期114-131,共18页
BACKGROUND Anastomotic leaks remain one of the most dreaded complications in gastrointestinal surgery causing significant morbidity,that negatively affect the patients’quality of life.Experimental studies play an imp... BACKGROUND Anastomotic leaks remain one of the most dreaded complications in gastrointestinal surgery causing significant morbidity,that negatively affect the patients’quality of life.Experimental studies play an important role in understanding the pathophysiological background of anastomotic healing and there are still many fields that require further investigation.Knowledge drawn from these studies can lead to interventions or techniques that can reduce the risk of anastomotic leak in patients with high-risk features.Despite the advances in experimental protocols and techniques,designing a high-quality study is still challenging for the investigators as there is a plethora of different models used.AIM To review current state of the art for experimental protocols in high-risk anastomosis in rats.METHODS This systematic review was performed according to The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.To identify eligible studies,a comprehensive literature search was performed in the electronic databases PubMed(MEDLINE)and Scopus,covering the period from conception until 18 October 2023.RESULTS From our search strategy 102 studies were included and were categorized based on the mechanism used to create a high-risk anastomosis.Methods of assessing anastomotic healing were extracted and were individually appraised.CONCLUSION Anastomotic healing studies have evolved over the last decades,but the findings are yet to be translated into human studies.There is a need for high-quality,well-designed studies that will help to the better understanding of the pathophysiology of anastomotic healing and the effects of various interventions. 展开更多
关键词 high-risk anastomosis RATS Experimental models BOWEL COLON Anastomotic leak Colon resection Inflammatory bowel disease Intra-abdominal sepsis Bursting pressure
下载PDF
回顾性分析脓毒症患者继发消化道出血的危险因素
6
作者 黎童 方向韶 王鹏飞 《岭南急诊医学杂志》 2024年第5期473-476,共4页
目的:本研究旨在分析脓毒症患者继发消化道出血(Gastrointestinal Bleeding,GIB)的危险因素。方法:回顾性分析2022年1月至2023年12月期间中山大学孙逸仙纪念医院急诊重症监护病房(EICU)收治的154例脓毒症患者的临床资料,根据是否发生GI... 目的:本研究旨在分析脓毒症患者继发消化道出血(Gastrointestinal Bleeding,GIB)的危险因素。方法:回顾性分析2022年1月至2023年12月期间中山大学孙逸仙纪念医院急诊重症监护病房(EICU)收治的154例脓毒症患者的临床资料,根据是否发生GIB分为两组:脓毒症继发GIB组(n=14)和脓毒症对照组(n=140)。比较两组患者的临床资料,并运用Logistic回归分析确定危险因素。结果:与脓毒症对照组相比,脓毒症继发GIB组患者的GIB病史、肝硬化病史、住院期间使用糖皮质激素、阿司匹林、纤维蛋白原、未成熟网织红细胞比率(Immature Reticulocyte Fraction,IRF)均显著升高。多因素Logistic回归分析表明住院期间使用阿司匹林、GIB病史、IRF升高为脓毒症继发GIB的独立危险因素。结论:使用阿司匹林、GIB病史、IRF升高均为脓毒症继发GIB的独立危险因素。 展开更多
关键词 脓毒症 消化道出血 危险因素 未成熟网织红细胞比率
下载PDF
不同抗凝方案在接受连续肾脏替代疗法的急诊脓毒症患者中的应用效果
7
作者 师延刚 于晓琳 +1 位作者 耿玉安 刘瑞芳 《河南医学研究》 CAS 2024年第2期341-344,共4页
目的对比不同抗凝方案在连续肾脏替代疗法(CRRT)的急诊脓毒症患者中的应用效果,并分析其对患者炎症状态及出血风险的影响。方法回顾性分析2020年1月至2022年12月医院收治的接受CRRT治疗的110例急诊脓毒症患者的资料,将接受低分子肝素抗... 目的对比不同抗凝方案在连续肾脏替代疗法(CRRT)的急诊脓毒症患者中的应用效果,并分析其对患者炎症状态及出血风险的影响。方法回顾性分析2020年1月至2022年12月医院收治的接受CRRT治疗的110例急诊脓毒症患者的资料,将接受低分子肝素抗凝的58例患者纳入对照组,将接受局部枸橼酸抗凝的52例患者纳入观察组。比较两组患者治疗前后炎症因子[肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)]与凝血功能指标[凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、纤维蛋白原(Fib)]水平,并采用房颤抗凝治疗出血评分系统评估两组患者治疗后的出血风险。结果治疗后,两组患者血清TNF-α、IL-6水平均降低,且观察组水平低于对照组(P<0.05);两组患者PT、APTT降低,Fib水平升高,且观察组PT、APTT低于对照组,Fib高于对照组(P<0.05)。观察组房颤抗凝治疗出血评分系统评分低于对照组(P<0.05)。结论与低分子肝素抗凝相比,采用局部枸橼酸抗凝方式可更好地减轻急诊脓毒症CRRT治疗患者炎症反应,改善凝血功能,降低出血风险。 展开更多
关键词 脓毒症 连续肾脏替代疗法 抗凝 炎症状态 出血风险
下载PDF
枸橼酸钠对脓毒血症伴高危出血行连续性肾替代治疗患者抗凝效果及安全性评价 被引量:11
8
作者 严斌 曹昉 +3 位作者 冷彦飞 王若霜 李磊 王学鹏 《中国急救复苏与灾害医学杂志》 2020年第5期573-576,共4页
目的研究构據酸纳腺毒血症伴高危出血行连续性肾脏替代治持(continuous renal replacement therapy,CRRT)患者的抗凝效果及安全性。方法:2016年2月-2018年2月凉山弈族自治州第一人民医院收治脓毒血症患者120例,均行CRRT治疗,随机分为观... 目的研究构據酸纳腺毒血症伴高危出血行连续性肾脏替代治持(continuous renal replacement therapy,CRRT)患者的抗凝效果及安全性。方法:2016年2月-2018年2月凉山弈族自治州第一人民医院收治脓毒血症患者120例,均行CRRT治疗,随机分为观察组和对照组,各60例,两组患者均接受抗感染、呼吸支持、营养支持、血管活性药物等标准治疗,行CRRT治疗,对照组采用低分子肝素抗凝,观察组采用局部枸橼酸抗凝。对比两组患者24h内血展氮(blood urea nitrogen,BUN)、肌肝(creatinine,Cr)、凝血功能指标变化[凝血酶时间(thrombin time,TT)、凝血酶原时间(Prothrombin time,PT)、活化部分凝血酶时间(activated partial thrombin time,APTT)、纤维蛋白原(fibrinogen,Fib)含量]、电解质变化[纳离子(Na^+)、钙离子(Ca^2+)、碳酸氢根(HCO3^-)]及肝功能指标变化[天门冬氨酸氨基转移酶(aspartate transaminase,AST)、丙氨酸氨基转移酶(alanine aminotransferase,ALT)、总胆红素(total bilirubin,TBiL)];统计两组患者出血、管路或滤器凝血发生率及滤器使用寿命。结果治疗24 h,两组BUN、Cr水平较治疗前均显著降低,观察组显著低于对照组(P>0.05);观察组TT、PT、APTT较治疗前未发生显著变化(P>0.05),对照组TT、PT、APTT较治疗前显著升高(P<0.05),两组Fib水平较治疗前均未发生显著变化(P>0.05);两组电解质水平和pH较治疗前未发生显著变化(P>0.05);两组ALT、TBiL水平较治疗前未发生显著变化(P>0.05)。观察组出血发生率和凝血发生率显著低于对照组(P<0.05),滤器平均使用寿命显著高于对照组(P<0.05)。结论在脓毒症伴高危出血行CRRT治疗患者中,枸橼酸抗凝可有效进行血液净化,且不影响患者全身凝血功能、电解质水平和肝功能,不增加出血风险,延长滤器使用寿命。 展开更多
关键词 枸橼酸抗凝 脓毒血症伴高危出血 连续性肾脏替代治疗 抗凝效果 安全性
下载PDF
低分子肝素对脓毒症患者预后及出血风险的Meta分析 被引量:13
9
作者 何丹 主有峰 +2 位作者 王珊 胡海 尹海燕 《中国感染控制杂志》 CAS 北大核心 2018年第8期670-678,共9页
目的系统评价低分子肝素(LMWH)对脓毒症患者预后及出血风险的影响。方法计算机检索英文数据库Cochrane Library Databases、PubMed、Embase,中文数据库维普全文电子期刊数据库、万方期刊数据库、中国知网数据库(CNKI)、中国生物医学文... 目的系统评价低分子肝素(LMWH)对脓毒症患者预后及出血风险的影响。方法计算机检索英文数据库Cochrane Library Databases、PubMed、Embase,中文数据库维普全文电子期刊数据库、万方期刊数据库、中国知网数据库(CNKI)、中国生物医学文献数据库,检索时间为1995年1月—2017年9月,主题为LMWH治疗脓毒症的随机对照临床研究。按照纳入与排除标准筛选文献,提取数据并进行质量评价,使用RevMan5.3软件进行Meta分析。结果最终纳入19项研究,共1 016例患者。19项研究对比了28天病死率,发现LMWH可降低脓毒症患者28天病死率[RR=0.52,95%CI(0.43~0.63),P<0.001];亚组分析纳入2项研究,发现LMWH可降低脓毒症合并急性肺损伤患者28天病死率[RR=0.40,95%CI(0.21~0.75),P=0.004];4项研究对比了重症监护病房(ICU)住院时间,发现LMWH对脓毒症患者ICU住院时间无明显影响[MD=-0.84,95%CI(-1.95~0.26),P=0.14];15项研究对比了LMWH对APACHEⅡ评分,发现LMWH可降低脓毒症患者7 d后APACHEⅡ评分[MD=-0.64,95%CI(-0.93~0.34),P=0.00];4项研究对比了LMWH对弥散性血管内凝血(DIC)发生率的影响,发现LMWH可降低脓毒症患者DIC的发生率[RR=0.34,95%CI(0.18~0.67),P=0.002];12项研究对比了LMWH对出血的影响,发现LMWH可增加脓毒症患者出血风险[RR=2.74,95%CI(1.60~4.71),P=0.00]。结论 LMWH可降低脓毒症患者28天病死率、改善预后,但增加出血发生率。 展开更多
关键词 低分子肝素 脓毒症 28天病死率 META分析 出血风险
下载PDF
Therapeutic strategies in Crohn’s disease in an emergency surgical setting 被引量:3
10
作者 Maria Michela Chiarello Gilda Pepe +4 位作者 Valeria Fico Valentina Bianchi Giuseppe Tropeano Gaia Altieri Giuseppe Brisinda 《World Journal of Gastroenterology》 SCIE CAS 2022年第18期1902-1921,共20页
Crohn’s disease(CD)remains a chronic,incurable disorder that presents unique challenges to the surgeon.Multiple factors must be considered to allow development of an appropriate treatment plan.Medical therapy often p... Crohn’s disease(CD)remains a chronic,incurable disorder that presents unique challenges to the surgeon.Multiple factors must be considered to allow development of an appropriate treatment plan.Medical therapy often precedes or complements the surgical management.The indications for operative management of CD include acute and chronic disease complications and failed medical therapy.Elective surgery comes into play when patients are refractory to medical treatment if they have an obstructive phenotype.Toxic colitis,acute obstruction,perforation,acute abscess,or massive hemorrhage represent indications for emergency surgery.These patients are generally in critical conditions and present with intra-abdominal sepsis and a preoperative status of immunosuppression and malnutrition that exposes them to a higher risk of complications and mortality.A multidisciplinary team including surgeons,gastroenterologists,radiologists,nutritional support services,and enterostomal therapists are required for optimal patient care and decision making.Management of each emergency should be individualized based on patient age,disease type and duration,and patient goals of care.Moreover,the recurrent nature of disease mandates that we continue searching for innovative medical therapies and operative techniques that reduce the need to repeat surgical operations.In this review,we aimed to discuss the acute complications of CD and their treatment. 展开更多
关键词 Crohn’s disease Intestinal obstruction Free perforation Intra-abdominal sepsis Perineal sepsis Acute bleeding
下载PDF
脓毒症继发消化道出血危险因素及预后分析 被引量:2
11
作者 胡向党 巴晓彤 朱萍 《临床和实验医学杂志》 2023年第19期2032-2035,共4页
目的 分析脓毒症继发消化道出血的危险因素及预后。方法 回顾性分析2020年1月至2023年1月北京市大兴区人民医院诊治124例脓毒症患者临床资料,根据是否继发消化道出血分为脓毒症组(n=84)和脓毒症继发消化道出血组(n=40)。分析并比较脓毒... 目的 分析脓毒症继发消化道出血的危险因素及预后。方法 回顾性分析2020年1月至2023年1月北京市大兴区人民医院诊治124例脓毒症患者临床资料,根据是否继发消化道出血分为脓毒症组(n=84)和脓毒症继发消化道出血组(n=40)。分析并比较脓毒症组和脓毒症继发消化道出血组患者临床资料的差异。Logistics回归分析脓毒症继发消化道出血的危险因素。采用受试者受试者工作特征(ROC)曲线分析危险因素预测脓毒症继发消化道出血敏感度及特异度。比较两组患者预后。结果 脓毒症组和脓毒症继发消化道出血组患者在性别、年龄、吸烟史、饮酒史、高血压史、糖尿病史、心脏病史、慢性呼吸道疾病史、白细胞计数(WBC)、D-二聚体、血红蛋白、纤维蛋白原降解产物(FDP)、丙氨酸转移酶(ALT)、天冬氨酸转移酶(AST)、总胆红素(TBIL)、肌酐、尿素氮、降钙素原、高敏C反应蛋白及静脉血栓栓塞症(VTE)评分方面比较,差异均无统计学意义(P>0.05);脓毒症继发消化道出血组患者抗凝药物使用史患者比率、消化道出血史患者比率、持续机械通气>4 d患者比率、住院期间糖皮质激素使用史患者比率、ICU住院时间、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、国际标准化比率(INR)、急性生理学和慢性健康状况评价(APACHEⅡ)评分、序贯器官衰竭估计(SOFA)评分均显著高于脓毒症组,血红蛋白、血小板计数(PLT)及APTT均显著低于脓毒症组,差异均有统计学意义(P<0.05)。Logistic回归分析表明抗凝药物使用史、消化道出血史、持续机械通气>4 d、住院期间糖皮质激素使用史、ICU住院时间、PLT、PT、APTT、INR、APACHEⅡ评分及SOFA评分为脓毒症继发消化道出血的影响因素。ROC曲线分析影响因素预测脓毒症继发消化道出血敏感度及特异度,其中PT敏感度最高,APTT的特异度最高。脓毒症继发消化道出血组患者病死率显著高于脓毒症组患者,差异有统计学意义(P<0.05)。结论 有抗凝药物使用史、有消化道出血史、持续机械通气>4 d、有住院期间糖皮质激素使用史、ICU住院时间长、凝血功能异常、APACHEⅡ评分高及SOFA评分高均为脓毒症继发消化道出血的危险因素,可显著增加患者死亡风险。 展开更多
关键词 脓毒症 消化道出血 危险因素 预后
下载PDF
十二指肠憩室溃疡并下腔静脉瘘致反复消化道大出血、脓毒血症1例报道 被引量:1
12
作者 朱晓红 王全楚 +1 位作者 张燕 梁栋 《胃肠病学和肝病学杂志》 CAS 2022年第1期109-110,共2页
十二指肠下腔静脉瘘是一种十分罕见的病变,患者多病情危重,短时间内诊断困难,死亡率极高。而十二指肠憩室多数并无明显症状,仅少数患者可出现梗阻、穿孔、出血等并发症。现就我院救治的十二指肠憩室溃疡并下腔静脉瘘致反复消化道大出血... 十二指肠下腔静脉瘘是一种十分罕见的病变,患者多病情危重,短时间内诊断困难,死亡率极高。而十二指肠憩室多数并无明显症状,仅少数患者可出现梗阻、穿孔、出血等并发症。现就我院救治的十二指肠憩室溃疡并下腔静脉瘘致反复消化道大出血、脓毒血症1例进行报道。 展开更多
关键词 十二指肠憩室 溃疡 下腔静脉瘘 消化道出血 脓毒血症
下载PDF
12例脓毒症相关性血小板减少症病人伴极高危出血风险的护理 被引量:1
13
作者 彭影 李娇 +1 位作者 张素兰 向明芳 《全科护理》 2022年第24期3393-3396,共4页
目的:总结12例脓毒症相关性血小板减少症病人的护理经验。方法:对脓毒症血小板减少症病人升血小板治疗中进行积极有效的护理,包括出血的预防与处理、静脉血栓预防、血糖控制及人文关怀等。结果:12例病人死亡3例,自动出院4例,其余5例病... 目的:总结12例脓毒症相关性血小板减少症病人的护理经验。方法:对脓毒症血小板减少症病人升血小板治疗中进行积极有效的护理,包括出血的预防与处理、静脉血栓预防、血糖控制及人文关怀等。结果:12例病人死亡3例,自动出院4例,其余5例病情好转转回普通病房继续治疗。结论:脓毒症相关性血小板减少症病人发病率高、死亡率高,除脓毒症相关治疗措施以外需快速提升病人血小板、做好出血的观察与预防处理,同时还需预防静脉血栓、落实家属探视制度、实施人文关怀等,能有效阻止病情发展,减少出血发生,提高病人家属满意度,降低脓毒症相关血小板减少症病人死亡率。 展开更多
关键词 脓毒症 血小板减少症 出血 护理
下载PDF
枸橼酸抗凝在脓毒症伴高危出血行连续性肾脏替代治疗患者中的应用效果 被引量:1
14
作者 赵志强 孟鹏飞 +2 位作者 石正松 陈亚君 肖宏涛 《医药论坛杂志》 2023年第19期14-18,共5页
目的分析枸橼酸抗凝在脓毒症伴高危出血行连续性肾脏替代治疗(continuous renal replacement therapy,CRRT)患者中的应用效果。方法纳入2020年1月至2022年12月在郑州市第一人民医院接受CRRT治疗且伴有高危出血风险的105例脓毒症患者作... 目的分析枸橼酸抗凝在脓毒症伴高危出血行连续性肾脏替代治疗(continuous renal replacement therapy,CRRT)患者中的应用效果。方法纳入2020年1月至2022年12月在郑州市第一人民医院接受CRRT治疗且伴有高危出血风险的105例脓毒症患者作为研究对象,应用随机数字表法分为无抗凝组、肝素组和枸橼酸组三组,每组35例。无抗凝组不采取任何抗凝治疗措施,肝素组给予低分子肝素进行抗凝治疗,枸橼酸组给予枸橼酸抗凝治疗,观察三组抗凝治疗前后凝血功能,统计两组过滤器使用时间、实际超滤量、抗凝效果及出血相关并发症发生情况。结果治疗后,三组凝血酶时间(TT)、凝血酶原时间(PT)、纤维蛋白原(FIB)和活化凝血酶时间(APTT)组间比较具有统计学意义(P<0.05),其中,无抗凝组TT、PT、APTT长于肝素组和枸橼酸组(P<0.05),无抗凝组FIB高于肝素组和枸橼酸组(P<0.05);治疗后枸橼酸组TT、PT、APTT短于肝素组(P<0.05),FIB高于肝素组(P<0.05)。三组的过滤器使用时间和实际超滤量组间比较具有统计学意义(P<0.05),其中,无抗凝组过滤器使用时间短于肝素组和枸橼酸组(P<0.05),实际超滤量低于肝素组和枸橼酸组(P<0.05),肝素组和枸橼酸组的过滤器使用时间和实际超滤量无统计学意义。三组透析器和灌流器的抗凝效果组间比较具有统计学意义(P<0.05),其中,无抗凝组透析器和灌流器的抗凝有效占比低于肝素组和枸橼酸组(P<0.05),肝素组和枸橼酸组的透析器和灌流器的抗凝有效占比差异无统计学意义(P>0.05)。三组透析器和灌流器的出血相关并发症总发生率组间比较具有统计学意义(P<0.05),其中,无抗凝组和枸橼酸组总发生率低于肝素组(P<0.05),无抗凝组和枸橼酸组总发生率无统计学意义(P>0.05)。结论枸橼酸抗凝在脓毒症伴高危出血行CRRT治疗患者中的应用效果良好,抗凝效果良好,可有效的延长过滤器使用时间,提高实际超滤量,且对患者的凝血功能影响较小,可减少出血性相关并发症的发生风险。 展开更多
关键词 枸橼酸 抗凝 脓毒症 高危出血 连续性肾脏替代治疗
原文传递
脓毒症患者实施应激性溃疡预防策略的效益与风险评价--基于大型数据库的回顾性队列研究 被引量:7
15
作者 黄敏强 匡蕾 +1 位作者 韩溟 韩伟 《中华危重病急救医学》 CAS CSCD 北大核心 2021年第6期641-647,共7页
目的评价在有消化道出血(GIB)风险的成人脓毒症患者中实施应激性溃疡预防(SUP)策略的效益与风险。方法采用回顾性队列研究方法,从电子重症监护病房协作研究数据库(eICU-CRD)中提取脓毒症患者的相关信息。按入住重症监护病房(ICU)2 d内... 目的评价在有消化道出血(GIB)风险的成人脓毒症患者中实施应激性溃疡预防(SUP)策略的效益与风险。方法采用回顾性队列研究方法,从电子重症监护病房协作研究数据库(eICU-CRD)中提取脓毒症患者的相关信息。按入住重症监护病房(ICU)2 d内是否接受质子泵抑制剂(PPI)或H_(2)受体拮抗剂(H_(2)RA)或两种联合/序贯治疗作为实施SUP策略进行预防应激性溃疡分为SUP组和未接受SUP组。比较使用SUP与未使用SUP两组患者的院内病死率、ICU住院时间、GIB以及继发性感染并发症发生率等临床结局指标的差异。倾向性评分匹配(PSM)用于平衡两组间的基线特征,并根据使用SUP时间是否≥3 d分为使用SUP<3 d组和使用SUP≥3 d组进行亚组分析,采用多因素Logistic回归分析影响GIB、继发性肺炎等结局的因素。结果共11413例患者最终纳入分析,其中SUP组9799例,未接受SUP组1614例。进行1∶1的PSM后两个队列均有1600例患者。①基线特征:与SUP组比较,未接受SUP组患者年龄较大〔岁:69.0(56.0,80.0)比67.0(56.0,78.0)〕,入住ICU时急性生理学与慢性健康状况评分Ⅳ(APACHEⅣ)及序贯器官衰竭评分(SOFA)均明显降低〔APACHEⅣ评分(分):65(50,73)比72(58,87),SOFA评分(分):5(4,7)比7(5,9)〕,高血压和糖尿病等基础疾病的比例更高〔高血压:15.6%(252/1614)比12.2%(1196/9779),糖尿病:4.5%(72/1614)比3.3%(325/9779),均P<0.05〕,表明SUP组患者的病情严重程度更重。②临床结局指标比较:PSM前,与未接受SUP组比较,SUP组院内病死率高〔17.2%(1688/9799)比10.9%(176/1614)〕,ICU住院时间长〔d:4.4(2.9,7.7)比3.1(2.5,4.3)〕,继发性肺炎发生率也较高〔11.3%(1112/9799)比6.8%(110/1614)〕,差异均有统计学意义(均P<0.05);而两组GIB和艰难梭菌感染(CDI)发生率比较差异均无统计学意义。PSM后,两组院内病死率、GIB发生率及CDI发生率比较差异均无统计学意义;而与未接受SUP组比较,SUP组ICU住院时间明显延长〔d:3.9(2.8,6.6)比3.1(2.5,4.3)〕,继发性肺炎发生率仍明显升高〔10.9%(174/1600)比6.8%(108/1600)〕,差异均有统计学意义(均P<0.05)。亚组分析显示:与使用SUP<3 d组比较,使用SUP≥3 d组患者疾病严重程度评分更高〔APACHEⅣ评分(分):66(51,79)比62(48,72),SOFA评分(分):6(4,8)比5(4,7),均P<0.05〕,且院内病死率、GIB及继发性肺炎发生率也更高(分别为16.4%比10.7%、6.1%比1.8%、19.0%比8.6%),ICU住院时间更长〔d:6.6(4.1,11.8)比3.5(2.6,5.3),均P<0.05〕。③多因素Logistic回归分析:对于GIB,与未接受SUP组比较,使用SUP≥3 d与更多的GIB相关〔优势比(OR)=1.84,95%可信区间(95%CI)为1.07-3.08,P=0.030〕,而SUP<3 d组GIB的比例更少(OR=0.57,95%CI为0.34-0.94,P=0.020);而对于继发性肺炎,与未接受SUP组比较,使用SUP≥3 d和SUP<3 d均增加了继发性肺炎发生的风险(OR值分别为2.95、1.34,95%CI分别为2.10-4.13、1.01-1.77,P值分别为<0.001、0.040)。结论有GIB风险的成人脓毒症患者接受SUP药物治疗,并未降低院内病死率和GIB发生率,反而增加了继发性肺炎发生率,延长了ICU住院时间。 展开更多
关键词 应激性溃疡预防 消化道出血 脓毒症 电子重症监护病房协作研究数据库
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部